Novartis steps up MS digital presence with iPhone app

Novartis ($NVS) has introduced a multiple sclerosis iPhone app to help patients track their symptoms and relapses, PMLiVE reports. The app allows users to record their symptoms, general well-being, medications and other factors. With patients sometimes going one year between consultations with healthcare professionals, a day-to-day record is likely to be more reliable than memory when recalling symptoms. Article